Over US$12 trillion of COVID-19 relief has been promised. If a small portion was put toward economy-boosting green investments, the world could get on track to avoid the worst of climate change.
Academic rigour, journalistic flair
Articles on Coronavirus
Displaying 1801 - 1820 of 5483 articles
Moderna’s shot is far easier to store and distribute than Pfizer’s. But there are concerns neither vaccine performs particularly well for older people.
While Chief Scientist Alan Finkel’s review of contact tracing only briefly mentions digital methods, it’s crucial Australia invests in an automated system.
Academics and others concerned with benefitting from peer professional collaboration can use COVID-19 disruptions as an opportunity to improve conferences through smart design.
In the current pandemic, finding the right balance between the protection of public health and respecting civil liberties has proven to be supremely difficult.
The recent vaccine trial results certainly look impressive, but here’s how to fully interrogate what they mean.
Whatever approach is taken, the vaccine roll-out has to be fair and efficient.
Scott Morrison is hopeful his national cabinet’s goal of an ‘open Christmas’ won’t be impeded by a cluster outbreak in South Australia.
South Australia’s COVID cluster is disappointing after a long stretch of no community transmission. Now we need to act to stop it growing exponentially.
To navigate the toughest phase of their careers, junior academics need to know more than how to write research papers and apply for grants. Structured mentoring, based on their input, is a huge help.
Distributing a vaccine is a bit like boarding a plane — we can’t all board at the same time. So who gets priority? There are a few reasons we should consider vaccinating older people first.
There’s no guarantee future COVID-19 vaccines will work in the elderly. So we can consider vaccinating the young first to protect them. Here’s what we need to work out first.
The federal government has concluded a $1 billion agreement for a new high-tech manufacturing facility in Melbourne which would produce pandemic influenza vaccines as well as antivenoms.
Canada has set aside a total of 414 million doses of different types of vaccine. Some exploit known mechanisms, others are based on previously untested approaches.
Good communication and factoring in human behaviours can prevent people from dismissing the risk of the coronavirus.
Governments can corner themselves by failing to recognise their own groupthink.
Biden will begin his presidency in the midst of a global public health crisis that’s already killed over 240,000 people in the US alone. His team is already planning how to get COVID-19 under control.
Fortifying essential food with sensible amounts of vitamin D is a cheap intervention that will have a small but important benefit.
The loss of the simple act of hugging has taken a big emotional toll for many people during the pandemic.
A chorus of prominent voices that seek to persuade Canadians that COVID-19 compliance is in everyone’s interest.
Top contributors
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Senior Research Fellow in Global Health, University of Southampton
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Associate Professor of Bioethics, University of Portsmouth
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Professor of Public Health, University of Sheffield
-
Professor of Medicine, University of East Anglia
-
Associate Professor, Director Cabrini Monash University Department of Nursing Research, Monash University
-
Senior Lecturer in Mathematical Biology, University of Bath
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Professor of Medicine, University of Virginia
